pharma · Shingles
Dynavax Technologies
Dynavax International B.V.
Dynavax International is a pharma organization headquartered in EU. Primary therapeutic focus areas include Shingles. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity f
Emeryville, USA HQ
313 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Emeryville, USA
- Employees
- 313
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Z-1018
Phase 1 · mab · Shingles
Z-1018 for Shingles is a Phase 1 program (mab) at Dynavax International B.V. with 1 ClinicalTrials.gov record(s).
Internal code DV2-ZOS-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Dynavax International B.V.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Shingles
- Status
- completed
- Trials
- 1